Búsqueda | Biblioteca Virtual en Salud Fronteriza

1.

Prognostic Value of the Progesterone Receptor by Subtype in Patients with Estrogen Receptor-Positive, HER-2 Negative Breast Cancer.

Van Asten, Kathleen; Slembrouck, Laurence; Olbrecht, Siel; Jongen, Lynn; Brouckaert, Olivier; Wildiers, Hans; Floris, Giuseppe; Van Limbergen, Erik; Weltens, Caroline; Smeets, Ann; Paridaens, Robert; Giobbie-Hurder, Anita; Regan, Meredith M; Viale, Giuseppe; Thürlimann, Beat; Vergote, Ignace; Christodoulou, Evangelia; Van Calster, Ben; Neven, Patrick.

Oncologist ; 24(2): 165-171, 2019 02.

Artículo en Inglés | MEDLINE | ID: mdl-30171067

2.

Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics.

Diéras, Véronique; Bonnefoi, Hervé; Alba, Emilio; Awada, Ahmad; Coudert, Bruno; Pivot, Xavier; Gligorov, Joseph; Jager, Agnes; Zambelli, Stefania; Lindeman, Geoffrey J; Charpentier, Eric; Emmons, Gary T; Garcia-Ribas, Ignacio; Paridaens, Robert; Verweij, Jaap.

Breast Cancer Res Treat ; 177(2): 383-393, 2019 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-31172407

3.

Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial.

Derks, Marloes G M; Blok, Erik J; Seynaeve, Caroline; Nortier, Johan W R; Kranenbarg, Elma Meershoek-Klein; Liefers, Gerrit-Jan; Putter, Hein; Kroep, Judith R; Rea, Daniel; Hasenburg, Annette; Markopoulos, Christos; Paridaens, Robert; Smeets, Jan B E; Dirix, Luc Y; van de Velde, Cornelis J H.

Lancet Oncol ; 18(9): 1211-1220, 2017 09.

Artículo en Inglés | MEDLINE | ID: mdl-28732650

4.

Androgen deprivation by adrenal suppression using low-dose hydrocortisone for the treatment of breast carcinoma with apocrine features: a case report illustrating this new paradigm.

Jongen, Lynn; Paridaens, Robert; Floris, Giuseppe; Wildiers, Hans; Neven, Patrick.

Breast Cancer Res Treat ; 155(3): 603-7, 2016 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-26868122

5.

Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients.

Vulsteke, Christof; Pfeil, Alena M; Maggen, Charlotte; Schwenkglenks, Matthias; Pettengell, Ruth; Szucs, Thomas D; Lambrechts, Diether; Dieudonné, Anne-Sophie; Hatse, Sigrid; Neven, Patrick; Paridaens, Robert; Wildiers, Hans.

Breast Cancer Res Treat ; 152(1): 67-76, 2015 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-26017071

6.

Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors.

Pfeil, Alena M; Vulsteke, Christof; Paridaens, Robert; Dieudonné, Anne-Sophie; Pettengell, Ruth; Hatse, Sigrid; Neven, Patrick; Lambrechts, Diether; Szucs, Thomas D; Schwenkglenks, Matthias; Wildiers, Hans.

BMC Cancer ; 14: 201, 2014 Mar 19.

Artículo en Inglés | MEDLINE | ID: mdl-24641830

7.

Prognostic impact of baseline serum C-reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib.

Beuselinck, Benoit; Vano, Yann-Alexandre; Oudard, Stéphane; Wolter, Pascal; De Smet, Robert; Depoorter, Lore; Teghom, Corine; Karadimou, Alexandra; Zucman-Rossi, Jessica; Debruyne, Philip R; Van Poppel, Hendrik; Joniau, Steven; Lerut, Evelyne; Strijbos, Michiel; Dumez, Herlinde; Paridaens, Robert; Van Calster, Ben; Schöffski, Patrick.

BJU Int ; 114(1): 81-9, 2014 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-24215209

8.

Efflux pump ABCB1 single nucleotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinib.

Beuselinck, Benoit; Lambrechts, Diether; Van Brussel, Thomas; Wolter, Pascal; Cardinaels, Nina; Joniau, Steven; Lerut, Evelyne; Karadimou, Alexandra; Couchy, Gabrielle; Sebe, Philippe; Ravaud, Alain; Zerbib, Marc; Caty, Armelle; Paridaens, Robert; Schöffski, Patrick; Verkarre, Virginie; Berger, Julien; Patard, Jean-Jacques; Zucman-Rossi, Jessica; Oudard, Stéphane.

Acta Oncol ; 53(10): 1413-22, 2014 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-24874929

9.

VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib - a multicentric retrospective analysis.

Beuselinck, Benoit; Karadimou, Alexandra; Lambrechts, Diether; Claes, Bart; Wolter, Pascal; Couchy, Gabrielle; Berkers, Joost; van Poppel, Hendrik; Paridaens, Robert; Schöffski, Patrick; Méjean, Arnaud; Verkarre, Virginie; Lerut, Evelyne; Joly, Florence; Lebret, Thierry; Gravis, Gwénaelle; Deplanque, Gael; Descazeaud, Aurélien; Leclercq, Nathalie Rioux; Molinié, Vincent; Patard, Jean-Jacques; Teghom, Corine; Elaidi, Reza; Zucman-Rossi, Jessica; Oudard, Stéphane.

Acta Oncol ; 53(1): 103-12, 2014 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-23421954

10.

Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysis.

van de Water, Willemien; Seynaeve, Caroline; Bastiaannet, Esther; Markopoulos, Christos; Jones, Steve E; Rea, Daniel; Hasenburg, Annette; Putter, Hein; Hille, Elysée T M; Paridaens, Robert; de Craen, Anton J M; Westendorp, Rudi G J; van de Velde, Cornelis J H; Liefers, Gerrit-Jan.

Oncologist ; 18(1): 8-13, 2013.

Artículo en Inglés | MEDLINE | ID: mdl-23263290

11.

Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency.

Hatse, Sigrid; Lambrechts, Diether; Verstuyf, Annemieke; Smeets, Ann; Brouwers, Barbara; Vandorpe, Thijs; Brouckaert, Olivier; Peuteman, Gilian; Laenen, Annouschka; Verlinden, Lieve; Kriebitzsch, Carsten; Dieudonné, Anne-Sophie; Paridaens, Robert; Neven, Patrick; Christiaens, Marie-Rose; Bouillon, Roger; Wildiers, Hans.

Carcinogenesis ; 33(7): 1319-26, 2012 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-22623648

12.

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial.

van de Velde, Cornelis J H; Rea, Daniel; Seynaeve, Caroline; Putter, Hein; Hasenburg, Annette; Vannetzel, Jean-Michel; Paridaens, Robert; Markopoulos, Christos; Hozumi, Yasuo; Hille, Elysee T M; Kieback, Dirk G; Asmar, Lina; Smeets, Jan; Nortier, Johan W R; Hadji, Peyman; Bartlett, John M S; Jones, Stephen E.

Lancet ; 377(9762): 321-31, 2011 Jan 22.

Artículo en Inglés | MEDLINE | ID: mdl-21247627

13.

Age-specific nonpersistence of endocrine therapy in postmenopausal patients diagnosed with hormone receptor-positive breast cancer: a TEAM study analysis.

van de Water, Willemien; Bastiaannet, Esther; Hille, Elysée T M; Meershoek-Klein Kranenbarg, Elma M; Putter, Hein; Seynaeve, Caroline M; Paridaens, Robert; de Craen, Anton J M; Westendorp, Rudi G J; Liefers, Gerrit-Jan; van de Velde, Cornelis J H.

Oncologist ; 17(1): 55-63, 2012.

Artículo en Inglés | MEDLINE | ID: mdl-22210087

14.

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.

Mouridsen, Henning; Giobbie-Hurder, Anita; Goldhirsch, Aron; Thürlimann, Beat; Paridaens, Robert; Smith, Ian; Mauriac, Louis; Forbes, John F; Price, Karen N; Regan, Meredith M; Gelber, Richard D; Coates, Alan S.

N Engl J Med ; 361(8): 766-76, 2009 Aug 20.

Artículo en Inglés | MEDLINE | ID: mdl-19692688

15.

Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia Study.

Schwenkglenks, Matthias; Pettengell, Ruth; Jackisch, Christian; Paridaens, Robert; Constenla, Manuel; Bosly, André; Szucs, Thomas D; Leonard, Robert.

Support Care Cancer ; 19(4): 483-90, 2011 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-20306092

16.

Meta-analyses of phase 3 randomised controlled trials of third generation aromatase inhibitors versus tamoxifen as first-line endocrine therapy in postmenopausal women with hormone receptor-positive advanced breast cancer.

Robertson, John F R; Paridaens, Robert J; Lichfield, Jasmine; Bradbury, Ian; Campbell, Christine.

Eur J Cancer ; 145: 19-28, 2021 03.

Artículo en Inglés | MEDLINE | ID: mdl-33418233

17.

Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies.

Robertson, John F R; Di Leo, Angelo; Johnston, Stephen; Chia, Stephen; Bliss, Judith M; Paridaens, Robert J; Lichfield, Jasmine; Bradbury, Ian; Campbell, Christine.

NPJ Breast Cancer ; 7(1): 11, 2021 Feb 12.

Artículo en Inglés | MEDLINE | ID: mdl-33579962

18.

Adjuvant trastuzumab in HER2-positive breast cancer.

Vanderhaegen, Joke; Paridaens, Robert; Neven, Patrick.

N Engl J Med ; 366(7): 664; author reply 664-6, 2012 02 16.

Artículo en Inglés | MEDLINE | ID: mdl-22335750

19.

Adjuvant! Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer.

Paridaens, Robert J; Gelber, Shari; Cole, Bernard F; Gelber, Richard D; Thürlimann, Beat; Price, Karen N; Holmberg, Stig B; Crivellari, Diana; Coates, Alan S; Goldhirsch, Aron.

Breast Cancer Res Treat ; 123(1): 303-10, 2010 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-20195744

20.

Additional value of PET-CT in staging of clinical stage IIB and III breast cancer.

Segaert, Isabelle; Mottaghy, Felix; Ceyssens, Sarah; De Wever, Walter; Stroobants, Sigrid; Van Ongeval, Chantal; Van Limbergen, Eric; Wildiers, Hans; Paridaens, Robert; Vergote, Ignace; Christiaens, Marie-Rose; Neven, Patrick.

Breast J ; 16(6): 617-24, 2010.

Artículo en Inglés | MEDLINE | ID: mdl-21070439

Biblioteca Virtual en Salud Fronteriza

México - Estados Unidos

Su selección (0)

Formato de exportación:

Exportar: